| abstract |
The present invention is directed to formulas (Ia), (Ib), (Ic), (Id), (Ie), (If), (Ig), (Ih), (I) as defined herein. Ii), (Ij), (Ik) or (Il) compounds, pharmaceutically acceptable salts, prodrugs, biologically active metabolites, stereoisomers and isomers of this compound, wherein Are defined herein. The compounds of the present invention are useful for the treatment of immunological and oncological conditions. |